Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on ...

Total consideration for the sale of FibroGen China to AstraZeneca now expected to be approximately $210 million, a $50 million increase from initial guidanceNet cash held in China at closing now ...

A new study from the Gray Faculty of Medical and Health Sciences at Tel Aviv University may mark a breakthrough in the ...

AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...

IonQ IONQ is rapidly positioning itself as a preferred partner for both commercial enterprises and government institutions ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

Boehringer Ingelheim's bid to return to the oncology arena has been achieved with an FDA approval for Hernexeos, a new, ...

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

Anish Dsilva & Prof. Ariel Munitz A new study from the Gray Faculty of Medical and Health Sciences at Tel Aviv University may ...